Elevation of plasma digoxin levels following concurrent administration
of nifedipine have previously been reported. The mechanism for this i
nteraction has not been fully explained, but may include a reduction i
n volume of distribution of digoxin and/or reduction in the renal or n
on-renal clearance of digoxin by nifedipine. The end result is probabl
y an elevation of plasma concentrations of free (pharmacologically act
ive) digoxin, which may lead to manifestation of side effects of digox
in. This communication highlights the possible pharmacokinetic basis o
f the reported digoxin-nifedipine interaction.